Rhovica Neuroimaging, a Swiss MedTech start-up, has raised CHF 2.3 million (EUR 2.5 million) in a financing round led by M2care, with participation from Kickfund, Valuemaker and several other business angels.
The funding will accelerate the development of SoNav, Rhovica’s bedside navigation system for extraventricular drainage (EVD) catheters used in emergency neurosurgery.
Rhovica addresses a critical challenge in emergency neurosurgery: the safe and fast placement of life-saving EVD catheters to relieve increased intracranial pressure, for example after severe trauma or intracranial bleeding.
Today, neurosurgeons typically perform this emergency procedure blindly. Real-time visualization and navigation is not available directly at the bedside increasing clinical risks.
SoNav system is designed to provide bedside real-time visualization and guidance to improve speed, accuracy and subsequent patient monitoring in intensive care. The company positions itself in the growing neurosurgical device market environment.
Rhovica Neuroimaging, founded in Bern in 2023 by neurosurgeons Martin Hlavica and Thomas Rhomberg, is pioneering solutions to improve emergency treatment for patients with life-threatening increased brain pressure.
 in a financing round led by M2care.){kind=link}